SEC Form 4 · accession 0001437749-16-028345
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Molly Hemmeter
Officer — Chief Executive Officer
Period of report
Mar 23, 2016
Accepted (ET)
Mar 24, 2016 · 3:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 23, 2016 | M | 37,500 | $6.47 | A | 37,500 | D | |
| Common StockF1 | Mar 23, 2016 | M | 23,329 | $10.40 | D | 14,171 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $10.40 | Mar 23, 2016 | X | 37,500 | D | Jun 22, 2010 | Jun 22, 2016 | Common Stock | 37,500 | 0 | D |
Explanation of responses
- F1Ms. Hemmeter surrendered to the Issuer the right to receive an aggregate of 23,329 shares of Common Stock. Ms. Hemmeter did not sell any shares of Common Stock in connection with the foregoing exercise.